Tfo Tdc, LLC Biogen Inc. Transaction History

Tfo Tdc, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$212.02 - $267.71 $612,101 - $772,878	-2,887 Reduced 99.9%	3 $0
Q4 2023 Feb 12, 2024	BUY	$222.59 - $267.94 $641,949 - $772,738	2,884 Added 48066.67%	2,890 $747,000
Q3 2023 Nov 02, 2023	BUY	$253.3 - $285.89 $759 - $857	3 Added 100.0%	6 $1,000
Q4 2022 Feb 03, 2023	BUY	$252.44 - $306.72 $757 - $920	3 New	3 $0

1,032

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Tfo Tdc, LLC, based on Form 13F filings with the SEC.

Stay updated on Tfo Tdc, LLC with notifications on news.